Treatmybrand


a Kainjoo SA Venture
Ch. du Vernay 14a
1196 Gland
+41.21.561.34.96
[email protected]

Support


Monday to Friday
8AM to 8PM
[email protected]
Back

Novartis Approaches Acquisition of Avidity Biosciences

Novartis, the Swiss pharmaceutical giant, is proposing to buy Avidity Biosciences at a price exceeding $70 per share.

Inc.
Inc.